Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Bonal DM"'
Autor:
Wong SQ; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA., Ryan CJ; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA., Bonal DM; Pathobiology Graduate Program, Division of Biology & Medicine, Brown University, Providence, Rhode Island, USA., Mills J; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.; Department of Biology, Wheaton College, Norton, Massachusetts, USA., Lapierre LR; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, Rhode Island, USA.; Département de Chimie et Biochimie, Université de Moncton, Moncton, New Brunswick, Canada.; New Brunswick Center for Precision Medicine, Moncton, New Brunswick, Canada.
Publikováno v:
Aging cell [Aging Cell] 2023 Mar; Vol. 22 (3), pp. e13741. Date of Electronic Publication: 2022 Nov 23.
Autor:
Treaba DO; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Bonal DM; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA., Chorzalska A; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA., Castillo-Martin M; Champalimaud Foundation, Lisbon, Portugal., Oakes A; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA., Pardo M; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA., Petersen M; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA., Schorl C; Genomics Core, Brown University, Providence, Rhode Island, USA., Hopkins K; Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Melcher D; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Zhao TC; Department of Surgery at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Liang O; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., So EY; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Reagan J; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Olszewski AJ; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Butera J; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Anthony DC; Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Rintels P; Hematology and Oncology Associates of Rhode Island, Cranston, Rhode Island, USA., Quesenberry P; Division of Hematology/Oncology at Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA., Dubielecka PM; Signal Transduction Lab, Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Rhode Island, Providence, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Mar; Vol. 200 (6), pp. 740-754. Date of Electronic Publication: 2022 Nov 10.
Autor:
Shi DD; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02215, USA; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Savani MR; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Medical Scientist Training Program, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Levitt MM; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Wang AC; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Endress JE; Ludwig Cancer Center, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA., Bird CE; Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA., Buehler J; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Stopka SA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Regan MS; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Lin YF; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Puliyappadamba VT; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Gao W; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Khanal J; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Evans L; Bayer HealthCare Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Lee JH; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Guo L; Quantitative Biomedical Research Center, Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Xiao Y; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Xu M; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Huang B; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Jennings RB; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02210, USA., Martin-Sandoval MS; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Dang T; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Gattie LC; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA., Cameron AB; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02210, USA., Lee S; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea., Asara JM; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Kornblum HI; Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Psychiatry and Behavioral Sciences, and Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA., Mak TW; The Campbell Family Institute for Breast Cancer Research, University Health Network, Toronto, ON M5G 2M9, Canada; The Princess Margaret Cancer Centre and Ontario Cancer Institute, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Looper RE; Department of Chemistry, University of Utah, Salt Lake City, UT 84112, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02210, USA., Signoretti S; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Gradl S; Bayer AG, Muellerstrasse 178, 13353 Berlin, Germany., Sutter A; Bayer AG, Muellerstrasse 178, 13353 Berlin, Germany., Jeffers M; Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ 07981, USA., Janzer A; Bayer AG, Muellerstrasse 178, 13353 Berlin, Germany., Lehrman MA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Zacharias LG; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Mathews TP; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Losman JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Richardson TE; Department of Pathology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX 78229, USA., Cahill DP; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., DeBerardinis RJ; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Pathology, Children's Hospital Boston, Boston, MA 02115, USA., Xu L; Quantitative Biomedical Research Center, Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA., Ly P; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Agar NYR; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Abdullah KG; Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; Hillman Comprehensive Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA., Harris IS; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: william_kaelin@dfci.harvard.edu., McBrayer SK; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA. Electronic address: samuel.mcbrayer@utsouthwestern.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Sep 12; Vol. 40 (9), pp. 939-956.e16. Date of Electronic Publication: 2022 Aug 18.
Autor:
Wang Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Buck A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Grimaud M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Culhane AC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.; Limerick Digital Cancer Research Center, Health Research Institute, School of Medicine, University of Limerick, Limerick V94 T9PX, Ireland., Kodangattil S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Razimbaud C; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhu Z; Harvard Medical School, Boston, MA 02115, USA.; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA., Wei K; Harvard Medical School, Boston, MA 02115, USA.; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA., O'Donnell ML; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Huang Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Signoretti S; Harvard Medical School, Boston, MA 02115, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Choueiri TK; Harvard Medical School, Boston, MA 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Freeman GJ; Harvard Medical School, Boston, MA 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhu Q; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Marasco WA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2021 Dec 31; Vol. 24, pp. 385-399. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2022).
Autor:
Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Speranza MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Eschle BK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Poitras MJ; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilkens MK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Chhoeu C; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Knott A; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lim-Fat MJ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Baker GJ; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts., Bonal DM; Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Nguyen QD; Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Grant GRL; University of Glasgow Medical School, Glasgow, Scotland, United Kingdom., Ligon KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Sorger PK; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts., Anderson AC; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Immunology, Blavatnik Institute, Harvard Medical School and Evergrande Center for Immunologic Diseases, Harvard Medical School, Boston, Massachusetts., Kirschmeier PT; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School and Evergrande Center for Immunologic Diseases, Harvard Medical School, Boston, Massachusetts., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. david_reardon@dfci.harvard.edu.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 276-287. Date of Electronic Publication: 2020 Nov 25.
Autor:
Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Sabet AH; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Gao W; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Chakraborty AA; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Schinzel AC; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Jennings RB; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Fonseca R; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Bonal DM; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02210, USA., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Flaifel A; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Novak JS; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Christensen CL; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Zhang H; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York 10016, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Buss EJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA., Wong KK; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York 10016, USA., Bronson RT; Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02215., Nguyen QD; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02210, USA., Signoretti S; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Massachusetts 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.
Publikováno v:
Genes & development [Genes Dev] 2019 Dec 01; Vol. 33 (23-24), pp. 1718-1738. Date of Electronic Publication: 2019 Nov 14.
Autor:
Anastas JN; Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Zee BM; Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Kalin JH; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Department of Medicine, Brigham and Womens Hospital, Boston, MA 02115, USA., Kim M; NYU Medical School, New York, NY 10016, USA., Guo R; Duke University, Durham, NC 27708, USA., Alexandrescu S; Department of Pathology Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Cancer Center, Boston, MA 02215, USA., Blanco MA; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Giera S; Sanofi, Cambridge, MA 02139, USA., Gillespie SM; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Das J; Eshelman School of Pharmacy, UNC Chapel Hill, Chapel Hill, NC 27599, USA., Wu M; Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA., Nocco S; Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Suva ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Alani R; Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA., Golub TR; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, 20815 MD, USA., Cole PA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Department of Medicine, Brigham and Womens Hospital, Boston, MA 02115, USA., Filbin MG; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Cancer Center, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: mariella.filbin@childrens.harvard.edu., Shi Y; Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: yang_shi@hms.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2019 Nov 11; Vol. 36 (5), pp. 528-544.e10. Date of Electronic Publication: 2019 Oct 17.
Autor:
Ding L; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Su Y; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Deciphera Pharmaceuticals, Waltham, MA, USA., Fassl A; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA., Hinohara K; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Nagoya University Graduate School of Medicine, Nagoya, Japan., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Huh SJ; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; ImmunoGen, Inc, Waltham, MA, USA., Bloushtain-Qimron N; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; EMEA Site Intelligence and Activation, Tel Aviv, Israel., Jovanović B; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Ekram M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; WuXi NextCODE, Cambridge, MA, USA., Zi X; Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.; Second Military Medical University, Shanghai, 200433, P.R. China., Hines WC; Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.; University of New Mexico School of Medicine, Albuquerque, NM, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Gil Del Alcazar C; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Caulfield RJ; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA., Merino VF; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Choudhury S; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Metamark Genetics Inc, Worcester, MA, USA., Ethington G; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Panos L; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Grant M; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Herlihy W; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Au A; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94143, USA., Rosson GD; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Argani P; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA.; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA., Allred DC; Department of Pathology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Babski K; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Kim EMH; Sutter Roseville Medical Center, Roseville, CA, 95661, USA.; Cancer Treatment Centers of America, Atlanta, GA, USA., McDonnell CH 3rd; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Wagner J; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Rowberry R; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Bobolis K; Sutter Roseville Medical Center, Roseville, CA, 95661, USA., Kleer CG; Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA., Hwang ES; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94143, USA.; Duke University, Durham, NC, USA., Blum JL; Baylor-Charles A. Sammons Cancer Center, Dallas, TX, 75246, USA., Cristea S; Department of Data Science, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health Boston, Boston, MA, 02215, USA.; Department of Stem Cell and Regenerative Biology, Harvard University Cambridge, Cambridge, MA, 02138, USA., Sicinski P; Department of Cancer Biology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA., Fan R; Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Sukumar S; Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA., Park SY; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Bissell M; Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA., Yao J; MD Anderson Cancer Center, Houston, TX, 77030, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, Boston, MA, 02215, USA. Kornelia_Polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. Kornelia_Polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. Kornelia_Polyak@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Kornelia_Polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA. Kornelia_Polyak@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2019 Sep 13; Vol. 10 (1), pp. 4182. Date of Electronic Publication: 2019 Sep 13.
Autor:
Palakurthi S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kuraguchi M; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zacharek SJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zudaire E; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Huang W; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bonal DM; Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Liu J; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Dhaneshwar A; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., DePeaux K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gowaski MR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bailey D; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Regan SN; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ivanova E; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ferrante C; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., English JM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Khosla A; PathAI, Boston, Massachusetts., Beck AH; PathAI, Boston, Massachusetts., Rytlewski JA; Adaptive Biotechnologies, Seattle, Washington., Sanders C; Adaptive Biotechnologies, Seattle, Washington., Laquerre S; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Bittinger MA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kirschmeier PT; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Packman K; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Janne PA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Moy C; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Wong KK; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York University, New York, New York., Verona RI; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania. rverona@its.jnj.com mlorenzi@its.jnj.com., Lorenzi MV; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania. rverona@its.jnj.com mlorenzi@its.jnj.com.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Sep; Vol. 7 (9), pp. 1457-1471. Date of Electronic Publication: 2019 Jul 22.
Autor:
Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Fonseca R; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Chakraborty AA; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Brough R; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Spektor A; Howard Hughes Medical Institute, Chevy Chase, Maryland.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts., Jennings RB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Flaifel A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Novak JS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Gulati A; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Buss E; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Howard Hughes Medical Institute, Chevy Chase, Maryland., Younger ST; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., McBrayer SK; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Cowley GS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Bonal DM; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brulle-Soumare L; XenTech, Genopole, France., Taylor P; IMED Oncology, AstraZeneca, Cheshire, United Kingdom., Cairo S; XenTech, Genopole, France., Ryan CJ; Systems Biology Ireland, University College Dublin, Dublin, Republic of Ireland., Pease EJ; IMED Discovery Sciences, AstraZeneca, Cambridge, United Kingdom., Maratea K; IMED Drug Safety and Metabolism, AstraZeneca, Boston, Massachusetts., Travers J; IMED Oncology, AstraZeneca, Cheshire, United Kingdom., Root DE; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Signoretti S; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Pellman D; Howard Hughes Medical Institute, Chevy Chase, Maryland.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts., Ashton S; IMED Oncology, AstraZeneca, Cheshire, United Kingdom., Lord CJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Barry ST; IMED Oncology, AstraZeneca, Cambridge, United Kingdom., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. William_Kaelin@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Howard Hughes Medical Institute, Chevy Chase, Maryland.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2019 Feb; Vol. 9 (2), pp. 230-247. Date of Electronic Publication: 2018 Oct 29.